Illumina Overview
- Founded
- 1998
- Status
- Public
- Employees
- 11,750
- Stock Symbol
- ILMN
- Investments
- 63
- Share Price
- $316.33
- (As of Monday Closing)
Illumina General Information
Description
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
- 5200 Illumina Way
- San Diego, CA 92122
- United States
+1 (858) 000-0000
Illumina Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $316.33 | $323.57 | $306.66 - $526.00 | $50.8B | 157M | 1.05M | $5.07 |
Illumina Financials Summary
|
In Thousands, USD |
TTM 31-Dec-2021 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 60,734,772 | 60,734,772 | 52,601,000 | 47,470,780 |
| Revenue | 4,526,000 | 4,526,000 | 3,239,000 | 3,543,000 |
| EBITDA | 1,196,000 | 1,196,000 | 1,051,000 | 1,283,000 |
| Net Income | 762,000 | 762,000 | 656,000 | 1,002,000 |
| Total Assets | 15,217,000 | 15,217,000 | 7,585,000 | 7,316,000 |
| Total Debt | 2,540,000 | 2,540,000 | 1,906,000 | 1,881,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Illumina Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Illumina‘s full profile, request access.
Request a free trialIllumina Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
This information is available in the PitchBook Platform. To explore Illumina‘s full profile, request access.
Request a free trialIllumina Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The co
Biotechnology
San Diego, CA
11,750
As of 2022
00000
0.00
0000-00-00
000000&0
00000000
sequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla
0000000000000
San Francisco, CA
000
As of 0000
00000
000000000
00000
0000000
fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia de
0000000000000
Menlo Park, CA
000
As of 0000
00000
000000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialIllumina Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fluidigm | Formerly VC-backed | San Francisco, CA | 000 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 000000000 | 00000 |
| 0000000000 0000000 | Formerly VC-backed | Seattle, WA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 | Corporate Backed or Acquired | San Diego, CA | 000 | 000000&0 | ||
| 000000000 | Formerly VC-backed | San Francisco, CA | 0 | 000000&0 |
Illumina Patents
Illumina Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210350873-A1 | Genome sequencing and detection techniques | Pending | 08-May-2020 | 000000000 | |
| US-20210350163-A1 | Equalization-based image processing and spatial crosstalk attenuator | Granted | 05-May-2020 | 000000000 | |
| US-11188778-B1 | Equalization-based image processing and spatial crosstalk attenuator | Active | 05-May-2020 | 00000000 | 00 |
| US-20210339457-A1 | Flow cells | Pending | 24-Apr-2020 | 0000000000 | |
| US-20210313009-A1 | Hardware accelerated k-mer graph generation | Pending | 07-Apr-2020 | G16B20/20 |
Illumina Executive Team (51)
Illumina Board Members (17)
| Name | Representing | Role | Since |
|---|---|---|---|
| Caroline Dorsa | Self | Board Member | 000 0000 |
| Frances Arnold Ph.D | Self | Board Member | 000 0000 |
| Francis DeSouza | Illumina | Chief Executive Officer and Board Member | 000 0000 |
| Gary Guthart Ph.D | Self | Board Member | 000 0000 |
| Gerald Möller Ph.D | Self | Board Member | 000 0000 |
Illumina Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialIllumina Investments & Acquisitions (63)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000 | 15-Sep-2021 | 0000000000 | Application Software | 000000000 | |
| 0000000 | 15-Sep-2021 | 0000000000 | Biotechnology | 000000000 | |
| 000000000 | 02-Sep-2021 | 0000 | 00000 | Diagnostic Equipment | |
| 00000 | 18-Aug-2021 | 0000000000 | 00.00 | Biotechnology | 0000000 0 |
| Pluton Biosciences | 10-Feb-2021 | Accelerator/Incubator | 00000 | Biotechnology | 000000000 |
Illumina Subsidiaries (8)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Illumina Ventures | Venture Capital | Foster City, CA | 2016 |
| 00000 | Biotechnology | Menlo Park, CA | 0000 |
| 00000000 000000000 | Accelerator/Incubator | Foster City, CA | 0000 |
| 000000000 | Laboratory Services (Healthcare) | Amsterdam, Netherlands | 0000 |
| 0000000000 | Other Healthcare Technology Systems | Victoria, Canada | 0000 |
Illumina Exits (14)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| 000000 00000000 00 | 15-May-2020 | 00000 00000 00 | 0000 | Completed |
|
| 0000000 | 26-Jan-2016 | 000000000000000000 | Completed |
|
|
| 0000000 00000000 | 09-Dec-2015 | 00000 00000 00 | Completed |
|
|
| 0000000 | 14-Oct-2015 | 00000 00000 00 | 00000 | Completed |
|
| Adaptive Biotechnologies | 06-May-2015 | Later Stage VC | 00000 | Completed |
|